Back to Cardiology
Cardiologyv2000Evidence-Based

TIMI Risk Score for STEMI

Estimates 30-day mortality in ST-elevation MI using 8 clinical variables (0-14 points). Derived from the InTIME II trial; helps risk-stratify STEMI patients at presentation.

Clinical Input Parameters

years
Range: 18 — 120 years
mmHg
Range: 40 — 300 mmHg
bpm
Range: 20 — 250 bpm
kg
Range: 25 — 300 kg
hours
Range: 0 — 72 hours
Clinical Assessment
Awaiting Parameters
timi stemi score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The TIMI Risk Score for STEMI is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

TIMI-STEMI = age_pts(0/2/3) + history(1) + hypotension(3) + tachycardia(2) + killip(2) + low_weight(1) + anterior(1) + late_treatment(1)

Clinical Pearls & Practice Notes

  • Maximum score is 14 points.
  • Mortality rates are 30-day all-cause mortality from the InTIME II derivation cohort (Morrow et al., Circulation 2000).
  • Derived in fibrinolysis-treated STEMI patients; apply cautiously in the primary-PCI era — absolute risks may differ but rank-ordering is preserved.
  • Killip class: I = no HF; II = rales/JVD; III = pulmonary edema; IV = cardiogenic shock.
  • Educational use only — not a substitute for clinical judgment.

Evidence & Literature Citations

  1. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. Circulation. 2000;102(17):2031-2037.

Score Interpretation Ranges

Very Low Risk0 – 0 pts

30-day mortality: 0.8%

Low Risk1 – 1 pts

30-day mortality: 1.6%

Low Risk2 – 2 pts

30-day mortality: 2.2%

Low-Intermediate Risk3 – 3 pts

30-day mortality: 4.4%

Intermediate Risk4 – 4 pts

30-day mortality: 7.3%

Intermediate-High Risk5 – 5 pts

30-day mortality: 12.4%

High Risk6 – 7 pts

30-day mortality: 16.1-23.4%

Very High Risk8 – 14 pts

30-day mortality: 27.4-35.9%

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.